Latest news with #OSCR
Yahoo
18 hours ago
- Business
- Yahoo
Why Oscar Health, Inc. (OSCR) Soared On Thursday
We recently published a list of . In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other best-performing stocks on Thursday. Oscar Health snapped a five-day losing streak on Thursday, jumping 10.6 percent to close at $15.65 apiece as investors resorted to bargain-hunting while waiting for more concrete developments on the Trump administration's Medicare Advantage review. Earlier this year, lawmakers passed a $5-trillion tax-and-spending package that shaves as much as $900 billion in Medicaid, which servers over 70 million low-income households. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Now, Senate Republicans to broaden savings by looking for supposed inefficiencies in the Medicare program for senior citizens. In the first quarter of the year, Oscar Health, Inc. (NYSE:OSCR) registered a 55-percent increase in attributable net income of $275 million versus the $177 million registered in the same period last year. Revenues rose by 42 percent to $3.046 billion from $2.142 billion year-on-year. Overall, OSCR ranks 5th on our list of best-performing stocks on Thursday. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Scotsman
3 days ago
- Business
- Scotsman
Charity begins with honesty among staff
Debbie McIlwraith Cameron on strengthening public trust in charities Sign up to our Scotsman Money newsletter, covering all you need to know to help manage your money. Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... It is a criminal offence to act, or continue to act, as a charity trustee if you are disqualified under the Charities and Trustee Investment (Scotland) Act 2005 and you may be liable on conviction to imprisonment, a fine or both. With such consequences, charities must have a working knowledge of the disqualification criteria. Existing criteria: You cannot be appointed, or continue to act, as a charity trustee if: (i) you have an unspent conviction for an offence involving dishonesty or under the 2005 Act; (ii) you are bankrupt/sequestrated; (iii) you have granted a Protected Trust Deed/entered into an Individual Voluntary Arrangement; (iv) you have been removed by a court from being a charity trustee, or (v) you have been disqualified from being a company director. Advertisement Hide Ad Advertisement Hide Ad Disqualification is determined before appointment, and if a trustee's personal circumstances change, they are under a duty to disclose this, as their appointment must automatically cease. Charities must employ due diligence when it comes to employee backgrounds, says Debbie McIlwraith Cameron While you may have to rely on information provided in good faith, there are publicly available methods to carry out due diligence, e.g. OSCR's searchable Record of Removed Persons on its website. Exemptions: An individual may apply for a waiver from OSCR for a specific charity, a type of charity or charities in general. Each case is considered and decided on its own merits. OSCR lists the variables and supporting evidence it will consider in its guidance. Some disqualification criteria are time-sensitive. Automatic disqualification because of a conviction, bankruptcy and a Protected Trust Deed only exists while they remain unspent and undischarged. Advertisement Hide Ad Advertisement Hide Ad The changes: The implementation of the Charities (Regulation and Administration) (Scotland) Act 2023 extends disqualification criteria in two ways. The automatic disqualification list will now include being convicted of the following offences: terrorism, money laundering, bribery, perverting the course of justice, wilful neglect of duty by a public official/misconduct in public office and sexual offences. The key change is that the criteria will now extend to employees/volunteers holding a role with 'senior management functions' within the charity, as well as charity trustees. The 2023 Act defines 'senior management function': (i) if the function relates to the management of the charity and the individual is not accountable to anyone higher within the charity, except the charity trustees (e.g. the Chief Executive role), or (ii) if the function relates to the control of money, and the only person the individual is accountable to (except the charity trustees) is someone else exercising a senior management function other than to do with the control of money (e.g. Finance Director). In guidance published by OSCR, the regulator is clear that an individual's role/job title is not the deciding factor; you must consider the function the individual undertakes. Advertisement Hide Ad Advertisement Hide Ad Practical implications: Before the extensions are implemented later this summer, charities should undertake due diligence to ascertain whether any of the current trustees would come under the extended criteria and update any appointment/induction policies, and consider if any of their employees/volunteers carry out 'senior management functions' and if they must cease to act. Trustees may wish to add the potential consequences of automatic disqualification (e.g. loss of the Chief Executive/Finance Director, trustee numbers being below the minimum) and mitigation methods (e.g. due diligence, ability to re-deploy within the organisation) to the charity's risk register. If an automatic disqualification event were to occur, depending on the circumstances, it would be advisable to seek HR/employment advice.
Yahoo
22-05-2025
- Business
- Yahoo
Why Oscar Health, Inc. (OSCR) Crashed Today
We recently published a list of . In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other firms that are drenched in red today. Ten companies pulled back on Wednesday, booking hefty losses during the trading session, with investor sentiment weighed down by a flurry of government policies and dismal earnings performance in the last quarter of the year. Meanwhile, the Dow Jones fell by 1.91 percent, the S&P 500 declined by 1.61 percent, and the tech-heavy Nasdaq dropped 1.41 percent. In this article, let us take a look at the 10 companies that led a poor performance during the day and explore the reasons behind their drop. To come up with the list, we considered only the stocks with a $2 billion market capitalization and $5 million in trading volume. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Oscar Health saw its share prices decline for a third straight day on Wednesday, slashing 9.78 percent to end at $14.86 each as investors sold off positions following news that the Trump administration is ramping up audits of insurance firms offering Medicare Advantage. On Wednesday, the Centers for Medicare and Medicaid Services said that it would employ an additional 2,000 encoders by September and use advanced technology systems to audit data and make sure diagnoses that claims from Medicare Advantage insurers are aligned with the patients' medical records. The agency said the initiative could claw back some $500 million a year for taxpayers. This means that Oscar Health, Inc. (NYSE:OSCR) would be included in the review, being one of the insurance firms offering such services. In other recent news, Oscar Health, Inc. (NYSE:OSCR) said it achieved a 55-percent increase in net income attributable to the company of $275 million versus the $177 million in the same period last year. Revenues were also higher by 42 percent to $3.05 billion from $2.14 billion year-on-year. Overall, OSCR ranks 3rd on our list of firms that are drenched in red today. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than OSCR but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
22-05-2025
- Business
- Yahoo
Why Oscar Health, Inc. (OSCR) Crashed Today
We recently published a list of . In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other firms that are drenched in red today. Ten companies pulled back on Wednesday, booking hefty losses during the trading session, with investor sentiment weighed down by a flurry of government policies and dismal earnings performance in the last quarter of the year. Meanwhile, the Dow Jones fell by 1.91 percent, the S&P 500 declined by 1.61 percent, and the tech-heavy Nasdaq dropped 1.41 percent. In this article, let us take a look at the 10 companies that led a poor performance during the day and explore the reasons behind their drop. To come up with the list, we considered only the stocks with a $2 billion market capitalization and $5 million in trading volume. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Oscar Health saw its share prices decline for a third straight day on Wednesday, slashing 9.78 percent to end at $14.86 each as investors sold off positions following news that the Trump administration is ramping up audits of insurance firms offering Medicare Advantage. On Wednesday, the Centers for Medicare and Medicaid Services said that it would employ an additional 2,000 encoders by September and use advanced technology systems to audit data and make sure diagnoses that claims from Medicare Advantage insurers are aligned with the patients' medical records. The agency said the initiative could claw back some $500 million a year for taxpayers. This means that Oscar Health, Inc. (NYSE:OSCR) would be included in the review, being one of the insurance firms offering such services. In other recent news, Oscar Health, Inc. (NYSE:OSCR) said it achieved a 55-percent increase in net income attributable to the company of $275 million versus the $177 million in the same period last year. Revenues were also higher by 42 percent to $3.05 billion from $2.14 billion year-on-year. Overall, OSCR ranks 3rd on our list of firms that are drenched in red today. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than OSCR but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-05-2025
- Business
- Yahoo
Oscar Health (NYSE:OSCR) Sees 35% Price Move Over Last Month
Oscar Health recently reported impressive financial results for the first quarter of 2025, showcasing a robust year-over-year growth in revenue and net income with earnings per share also on the rise. These strong financial indicators have been accompanied by a significant price move of 35% over the past month. Oscar Health's performance might have added weight to broader market trends, as the market itself has risen by approximately 4% over the past week. In this context, Oscar Health's significant price movement highlights investor enthusiasm in response to the company's operational success. We've identified 1 weakness for Oscar Health that you should be aware of. We've found 16 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent impressive financial results from Oscar Health have been a catalyst for its significant short-term share price movement, reflecting investor optimism. However, over the past three years, Oscar Health's total return, inclusive of share price appreciation and dividends, reached 181.06%. This positive performance highlights the company's potential to weather challenges and maintain growth, despite its underperformance relative to the US insurance industry and market over the past year. The news of strong Q1 performance, underscored by year-over-year growth in revenue and net income, might bolster confidence in future revenue and earnings forecasts. The integration of AI and expansion into new markets could maintain a positive trajectory in Oscar Health's long-term efficiency and success. Despite these opportunities, uncertainties such as regulatory changes and market conditions remain potential risks to forecasts. The current share price movement appears promising when compared to the consensus analyst price target of US$19.36. With the shares currently trading at US$13.07, there exists a potential upside relative to the price target. Investors will have to weigh existing growth prospects against projected risks to decide if the current valuation aligns with future performance expectations. The analysis detailed in our Oscar Health valuation report hints at an inflated share price compared to its estimated value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:OSCR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
